South Bangalore Emerges As Prime Real Estate Hotspot With 15.1% YoY Demand Growth And 23.5% Capital Appreciation

South Bangalore is rapidly emerging as a prime real estate hotspot, with demand, capital appreciation, and rental growth soaring beyond expectations.

With a remarkable 15.1% year-on-year (YoY) increase in demand, South Bangalore is setting the pace for the city, far surpassing Bangalore’s overall market growth of 3.41%, shared Magicbricks, India’s leading real estate portal.

The portal further shared that South Bangalore’s real estate market has seen an impressive capital appreciation rate of 23.5% YoY, outpacing Bangalore's average of 20.9%. Property rates in South Bangalore have surged by 14% in just nine months, climbing from Rs 7,177 per square foot in January-March (JFM) 2024 to Rs 8,205 per square foot in July-September (JAS) 2024.

This surge reflects the market's dynamism, with property prices continuing to rise, making it a prime location for buyers to invest before prices increase further.

The portal further observed that South Bangalore remains a strong market for 2 and 3 BHK homes, which are highly sought after by families and professionals alike. The average price for a 2 BHK unit is ?7,595 per square foot, with prices ranging from Rs 69.2 lakh to Rs 82.7 lakh, depending on unit size. For a 3 BHK home, the price averages Rs 9,970 per square foot, with a price range of Rs 1.48 crore to Rs 1.9 crore.

Kanakapura Road stands out as a premium locality with property prices around Rs 9,380 per square foot, providing a serene environment surrounded by nature and cultural heritage. JP Nagar and Bannerghatta Road present more affordable options, with prices at ?8,350 and ?7,300 per square foot, respectively, making them ideal for families looking for developed infrastructure and easy access to essential services. Electronic City, priced at ?5,950 per square foot, remains an attractive option for investors and first-time buyers due to its proximity to major IT and industrial hubs.

Eurogrip India Launches Trailhound Tyres At “EICMA 2024”

* First look: Trailhound Wild – for adventure motorcycles & Bee Wild – for adventure scooters  

* Flagship range of two-wheeler tyres showcased at the global event

Eurogrip Tyres, India’s leading tyre manufacturer, launched the Trailhound family of tyres with two variants - Trailhound STR, designed for Adventure motorcycles and Trailhound SCR which are specific to Classics/Scramblers or Café Racers. The new products were showcased at EICMA 2024.

Eurogrip Tyres also showcased its flagship range of two-wheeler tyres at the 110th edition of the show, which began on November 5th and will go on till November 10th at Milan Rho-Fiera, Italy.

About the launch of the Trailhound products at the prestigious event, P Madhavan, Executive Vice-President - Marketing & Sales, TVS Srichakra Ltd, said, “Eurogrip has always valued participating in EICMA, for us this has been one of the most important international platforms to showcase our products. It is a pleasure to engage with varied audience at the show - riders, customers, business partners, global 2-wheeler manufacturers and more. Building Eurogrip as a strong global consumer brand and expanding to global markets is a key agenda for us, we have set our path right to fulfil these ambitions.” 

There was also a line-up of other products that cover a majority of two wheelers – from scooters (BEE family) to naked bikes and tourers (ROADHOUND), sports bikes (PROTORQ EXTREME) and off-roaders (CLIMBER XC, XC-R & MX Junior), at the event.

Eurogrip’s products are designed and tested to deliver exceptional performance. Its exhaustive product range, robust design and best-in-class tyre technology is enabling the brand to spread its reach in many continents, including Europe. Its product range expansion and market penetration has been very promising over the last few years.

Cummins India Limited - Results For The Quarter And Period Ended September 30, 2024

Cummins India Limited (NSE: CUMMINSIND, BSE: 500480) – The Board of Directors of Cummins India Limited (CIL), at their meeting held today, reviewed, and approved the unaudited financial results for the quarter and period ended September 30, 2024.

Performance Highlights (based on standalone unaudited financial results) for the quarter ended September 30, 2024:

Total Sales for the quarter at Rs 2,448 Cr. higher by 31% compared to the same quarter last year and higher by 8% compared to the previous quarter.

Domestic sales at Rs 2,008 Cr. higher by 47% compared to the same quarter last year and higher by 7% compared to the previous quarter.

Exports Sales at Rs  440 Cr. lower by 13% compared to the same quarter last year and higher by 13% compared to the previous quarter.

Profit before tax at Rs 594 Cr. is higher by 39% compared to the same quarter last year and higher by 8% compared to the previous quarter.

Profit after tax at Rs 451 Cr. is higher by 37% compared to the same quarter last year and higher by 7% compared to the previous quarter.

Shveta Arya, Managing Director, Cummins India Limited, said:

The Indian economy continues to remain resilient despite increasingly intense geopolitical conflicts. GST collections continue to remain strong, indicating robust underlying trade activities, while other key economic indicators like IIP, PMI are pointing to a reasonable economic outlook for the year.

With stable fiscal and monetary policies, the Government’s continued emphasis on infrastructure development, and PLI-led capex, the Indian economy is on course for growth in the range of 6.8% to 7.2%, according to various estimates. Cummins India Limited continues to execute its profitable growth strategy and is well-positioned to meet the demands of its end markets. At the same time, internationally, geopolitical risks and conflicts continue to pose uncertainty about global trade and supply chain disruptions.

Effective July 1, 2024, with a complete transition to CPCB IV+ emission norms for the applicable products, the company is well-positioned and had all its products certified well ahead of the time.

Future Outlook:

The Company has a strong portfolio of CPCB IV+ emission norms-compliant products to meet customer demand across the entire product range. With the transition to new emission norms, we remain cautiously optimistic about the demand outlook for the near term and optimistic about the long-term growth prospects.

Regarding exports, the company continues to work closely with its trade partners to drive growth in respective end markets. We remain cautiously optimistic about the export demand recovery as the economic and geopolitical events have impacted the end markets. With its diversified portfolio of products, company remains optimistic about the recovery in exports demand.

The Company has access to latest technology, a trusted brand, wide range of incredible products, world-class manufacturing capabilities, best-in-class talent, and a customer-centric service organization with an extensive distribution and service network throughout the country and neighboring regions. The company is well-positioned with a strong balance sheet and liquidity position to support profitable growth.

About Cummins India Limited:

Established in 1962 and headquartered in Pune, Cummins India Limited (NSE: CUMMINSIND | BSE: 500480) is one of the leading power solutions providers in the country. As the oldest Cummins entity in India, Cummins India Limited is involved in the power generation, aftermarket, and export businesses. The company has a strong manufacturing backbone and has five state-of-the-art manufacturing plants, assembly, and distribution facilities. With over 480 customer touchpoints, the company is committed to powering the success of its customers and ensuring that its services and solutions are readily accessible. The company has over 3,000 employees who contribute their expertise and commitment to ensuring Cummins India delivers on its mission of “making people’s lives better by powering a more prosperous world”.

Manipal Academy of Higher Education To Hosts 32nd Convocation Ceremony Over Three Day Celebration At KMC Greens, Manipal

* 32nd Convocation will facilitate the graduation of 5767 MAHE students

 Manipal Academy of Higher Education (MAHE), an Institution of Eminence, deemed to be University, one of India's leading research focused educational institution, is hosting its 32nd Convocation Ceremony over three days, from 8th till 10th of November at KMC Greens, Manipal. The 32nd edition of the convocation aims at celebrating the achievements of its latest graduating class and will gather esteemed faculty, distinguished guests, and families to honor the academic accomplishments of the students.

The chief guests for each day respectively will be Prof. Mamidala Jagadesh Kumar, Chairman UGC; Dr. Indrajit Bhattacharya, Director General, NIRA, New Delhi; and Dr Rajiv Bahl, Secretary to Government of India, Department of Health Research & Director General, Indian Council of Medical Research (ICMR).

The convocation will facilitate the graduation of 5767 MAHE students over the three-day event. Nine outstanding students from various colleges at MAHE Manipal will be awarded the prestigious Dr. TMA Pai Gold Medal in 2024 for their exceptional contributions and achievements in their respective fields. This accolade will honor their commitment to academic excellence and exemplary performance across diverse disciplines, reflecting MAHE's dedication to fostering talent and excellence in higher education.

For more information, kindly visit: https://www.manipal.edu/mu/academics/convocation.html

Visit our website for live updates on the convocation program: https://social.manipal.edu/live/

About Manipal Academy of Higher Education:

Manipal Academy of Higher Education (MAHE) is an Institution of Eminence Deemed-to-be University. MAHE offers over 400 specializations across the Health Sciences (HS), Management, Law, Humanities & Social Sciences (MLHS), and Technology & Science (T&S) streams; through its constituent units at campuses in Manipal, Mangalore, Bangalore, Jamshedpur, and Dubai. With a remarkable track record in academics, state-of-the-art infrastructure, and significant contributions to research, MAHE has earned recognition and acclaim both nationally and internationally. In October 2020, the Ministry of Education, Government of India, awarded MAHE the prestigious Institution of Eminence status. Currently ranked 4th in the National Institutional Ranking Framework (NIRF), MAHE is the preferred choice for students seeking a transformative learning experience and an enriching campus life, as well as for national & multi-national corporates looking for top talent.

Medtronic Unveils Outcomes Of The Largest Multi-Centric Prospective Stroke Registry On Mechanical Thrombectomy In India (PRAAN)

-First dedicated industry sponsored registry on the use of mechanical thrombectomy devices in patients for acute ischemic stroke (AIS) resulting in great functional and performance outcomes with low mortality rate

-These results corroborate the evidence that Mechanical Thrombectomy is safe and effective treatment for AIS in Indian Population

Medtronic, a global leader in healthcare technology, unveiled results from the Prospective Registry for Assessment of Acute Ischemic Stroke Patients Treated with stroke Devices in India (PRAAN) at the World Stroke Congress 2024, held in Abu Dhabi. PRAAN is India’s first industry-sponsored dedicated registry on mechanical thrombectomy, collecting real-world data on the use of stroke devices in patients with acute ischemic stroke (AIS) caused by large vessel occlusion.

The multi-centre study evaluates the clinical outcomes associated with market-released stroke devices of Medtronic for AIS patients with large vessel occlusion condition. The PRAAN registry enrolled 200 patients over 24 months, across 14 centers, and demonstrated that mechanical thrombectomy is a safe, effective, as well as cost-effective treatment for AIS in India.

In India, approximately 1.18 million patients experience stroke annually, with around 21% being suitable for mechanical thrombectomy procedures. Mechanical thrombectomy is a minimally invasive surgery to remove the brain clot. The current adoption rate of mechanical thrombectomy is less than 0.1% in India, generally owing to lack of awareness and access. The PRAAN study aims to bridge this gap by providing real-world data to healthcare professionals and policy makers, thus enabling them to strengthen stroke management in India by improving accessibility and adoption.

The data from the PRAAN study demonstrated high rates of positive functional outcomes and procedural success of mechanical thrombectomy with a low mortality rate in AIS patients. Additionally, the health economic analysis revealed that mechanical thrombectomy (MT) alone or in combination with intravenous tissue plasminogen activator (IV-tPA) appears to be cost-effective compared to IV-tPA treatment alone.

Highlights of the outcomes from the PRAAN Study

·       The results from the study are comparable to the global clinical registries and randomized clinical trials.

·       The success rate of revascularization, which means clearing a blood clot and getting blood flowing again in the vessel, is 87.4% after the final attempt.

·       After 90 days following the procedure, 65.8% of the patients had little or no disability.                                    

·       MT treatment is cost-effective as it helps people live better lives following a stroke. Patients treated with MT improved more after 90 days than those who only got IV-tPA treatment

Discussing the PRAAN registry, Mandeep Singh Kumar, Vice President and Managing Director, Medtronic India, said, “Stroke is the fourth leading cause of death in India, making it one of the top non-communicable diseases in the country. Medtronic is committed to advancing innovative and effective treatments for stroke, aiming to enhance patient outcomes as part of its mission to alleviate pain, restore health, and extend life. PRAAN is a first-of-its kind multi-centric prospective stroke clinical registry in India that tracks and reports on mechanical thrombectomy. We are confident that the data and outcomes from the study will help ignite critical discourse to raise awareness about the dangers of stroke and available treatment pathways and will empower healthcare professionals and policy makers alike in providing the right resources and guidance for the Indian public.”

Dr. Mathew Cherian, HOD Intervention Radiology at KMCH, Coimbatore, said, “A cerebral infarction caused by a blockage in the brain's blood vessels can result in permanent disability or death. However, thanks to mechanical thrombectomy, patients now have a treatment option available that can enable them to regain their mobility and resume their day-to-day activities. A recent multi-center trial conducted in India by Medtronic has once again proven the remarkable effectiveness of this groundbreaking stroke treatment in India.”

Dr. Vikram Huded, Director and Clinical Lead, Interventional Neurology Programme of NH group, Head of Neurology, Narayana Health, Bengaluru, commented,” Stroke is a medical emergency impacting millions of lives. Mechanical thrombectomy is a revolutionary treatment that has increased the treatment window up to 24 hours since the onset of symptoms in stroke. However, it is important to assess the impact of the procedure with the Indian patient pool and for that Medtronic has conducted the PRAAN study in India. The study has demonstrated good clinical outcomes like 65.8% had mRS score between 0-2 at 90 days follow-up which provides us the assurance about the efficacy of MT among Indian patients.”

About Medtronic: 

Bold thinking. Bolder actions. We are Medtronic. Medtronic plc, headquartered in Galway, Ireland, is the leading global healthcare technology company that boldly attacks the most challenging health problems facing humanity by searching out and finding solutions. Our Mission — to alleviate pain, restore health, and extend life — unites a global team of 95,000+ passionate people across more than 150 countries. Our technologies and therapies treat 70 health conditions and include cardiac devices, surgical robotics, insulin pumps, surgical tools, patient monitoring systems, and more. Powered by our diverse knowledge, insatiable curiosity, and desire to help all those who need it, we deliver innovative technologies that transform the lives of two people every second, every hour, every day. Expect more from us as we empower insight-driven care, experiences that put people first, and better outcomes for our world. In everything we do, we are engineering the extraordinary. For more information on Medtronic, visit www.Medtronic.com and follow Medtronic on LinkedIn.

Any forward-looking statements are subject to risks and uncertainties such as those described in Medtronic's periodic reports on file with the Securities and Exchange Commission. Actual results may differ materially from anticipated results. No statements or comments made in this release may be construed as medical advice and patients need to consult their physicians for the same.

SAP's Executive And Supervisory Boards In Bengaluru This Week

Photo Caption: : SAP reinforcing commitment to India, and shaping strategies for a future-ready economy. Seen in the picture, are Christian Klein, CEO SAP; Dr. H. C. Mult. Pekka Ala-Pietilä, Chairman of the Supervisory Board SAP SE; Thomas Saueressig, Head of Customer Innovation Delivery; Muhammad Alam, Head of SAP Product Engineering; Paul Marriott, SAP APJ President;  Sindhu Gangadharan, MD, SAP Labs India and Head, Customer Innovation Services, SAP; and Manish Prasad, President and Managing Director, SAP Indian Subcontinent.

Samsung Announces Biggest Ever Festive Offers On Galaxy Z Fold6 And Z Flip6 In India

* Consumers purchasing Samsung’s sixth generation foldables will additionally get Galaxy Z Assurance worth up to INR 14999 at just INR 999

Samsung, India’s largest consumer electronics brand, today announced exciting limited period offers on its immensely popular sixth-generation foldable smartphones - Galaxy Z Fold6 and Galaxy Z Flip6. 

Starting today, consumers purchasing Galaxy Z Fold6 will get the smartphone at as low as INR 144999 along with a 24 months no-cost EMI. Similarly, consumers purchasing Galaxy Z Flip6 will get the device at just INR 89999 with 24 months no-cost EMI as a part of a limited period festive offer. Galaxy Z Fold6 is priced starting INR 164999 and Galaxy Z Flip6 is priced starting INR 109999. Consumers seeking enhanced affordability can take advantage of the convenient EMI options starting as low as INR 2500 for Galaxy Z Flip6 and INR 4028 for Galaxy Z Fold6. 

Additionally, customers purchasing Galaxy Z Fold6 or Galaxy Z Flip6 will get Galaxy Z Assurance at just INR 999 for a limited period. The Galaxy Z Assurance programme, which provides complete device protection was originally priced at INR 14999 for Galaxy Z Fold6 and INR 9999 for Galaxy Z Flip6.  Under the Z Assurance programme, customers can now avail two claims in a year. 

Galaxy Z Flip6 and Galaxy Z Fold6 are the slimmest and lightest Galaxy Z series devices ever, and come with perfectly symmetrical design with straight edges. The Galaxy Z series is also equipped with enhanced Armor Aluminum and Corning Gorilla Glass Victus 2, making this the most durable Galaxy Z series yet. Galaxy Z Fold6 and Flip6 are equipped with the Snapdragon® 8 Gen 3 Mobile Platform for Galaxy, one of the most advanced Snapdragon mobile processors yet, combining best-in-class CPU, GPU, and NPU performance. The processor is optimized for AI processing and offers enhanced graphics along with improved overall performance.

The Galaxy Z Fold6 offers a range of AI-powered features and tools – Note Assist, Composer, Sketch to Image, Interpreter, Photo Assist and Instant Slow-mo – to maximize the large screen and significantly enhance your productivity. Galaxy Z Fold6 now comes with 1.6x larger vapor chamber for longer gaming sessions and ray tracing supports life-like graphics on its 7.6-inch screen that offers a brighter display of up to 2600 nits to deliver more immersive gaming.

The Galaxy Z Flip6 offers a range of new customization and creativity features so users can make the most of every moment. With the 3.4-inch Super AMOLED FlexWindow, consumers can use AI-assisted functions without even needing to open the device. Users can reply to texts with suggested replies, which analyzes their latest messages to suggest a suitable tailored response.

FlexCam now comes with the new Auto Zoom to compose the best framing for shots by detecting the subject and zooming in and out before making any necessary adjustments. The new 50MP Wide and 12MP Ultra-wide sensors provide an upgraded camera experience with clear and crisp details in pictures. Galaxy Z Flip6 now also comes with enhanced battery life and gets a vapor chamber for the first time.

Samsung Knox, Samsung Galaxy’s defense-grade, multi-layer security platform built to safeguard critical information and protect against vulnerabilities with end-to-end hardware, real-time threat detection and collaborative protection, secures Galaxy Z Fold6 and Z Flip6.

Galaxy Z Fold6 is available in three stunning colours- Silver Shadow, Navy Blue and Pink whereas Galaxy Z Flip6 is available in Silver Shadow, Mint and Blue. Both the devices are available across all leading online and offline retail stores.

About Samsung Electronics Co., Ltd.

Samsung inspires the world and shapes the future with transformative ideas and technologies. The company is redefining the world of TVs, smartphones, wearable devices, tablets, digital appliances, network systems and memory, system LSI, foundry and LED solutions. For latest news on Samsung India, please visit Samsung India Newsroom at http://news.samsung.com/in. For Hindi, log on to Samsung Newsroom Bharat at https://news.samsung.com/bharat. You can also follow us on Twitter @SamsungNewsIN